WPRIM Management System> DCMS> Kidney Research and Clinical Practice> 2012> 31

Volume: 31

1. Percutaneous renal biopsy should be considered as a daycare procedure in select patients. Page:83—84
2. Clinical usefulness of spot urine albumin-to-osmolality ratio for predicting 24-hour urinary albumin excretion. Page:81—82
3. Stroke in dialysis patients. Page:79—80
4. A case of Creutzfeldt-Jakob disease in a patient on hemodialysis. Page:76—78
5. Inherited protein S deficiency due to a novel nonsense mutation in the PROS1 gene in the patient with recurrent vascular access thrombosis: A case report. Page:72—75
6. Brief Report: Renal replacement therapy in Korea, 2010. Page:62—71
7. The effect of depression and health-related quality of life on the outcome of hemodialysis patients. Page:54—61
8. The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia. Page:48—53
9. Association between vascular access failure and microparticles in hemodialysis patients. Page:38—47
10. The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities. Page:26—37
11. Cardiorenal syndrome and vitamin D receptor activation in chronic kidney disease. Page:12—25
12. Smads as therapeutic targets for chronic kidney disease. Page:4—11
13. Vitamin C and functional iron deficiency anemia in hemodialysis. Page:1—3
14. The use of tacrolimus in the management of minimal change disease. Page:257—258
15. A case of membranous nephropathy associated with relapsing polychondritis. Page:253—256
16. Acute oxalate nephropathy caused by ethylene glycol poisoning. Page:249—252
17. Bilateral gluteal compartment syndrome complicated by rhabdomyolysis and acute kidney injury in a patient with alcohol intoxication. Page:246—248
18. Renal artery thrombosis secondary to sepsis-induced disseminated intravascular coagulation in acute pyelonephritis. Page:242—245
19. Impact of gene polymorphisms of interleukin-18, transforming growth factor-beta, and vascular endothelial growth factor on development of IgA nephropathy and thin glomerular basement membrane disease. Page:234—241
20. Endothelium-dependent vasodilation by ferulic acid in aorta from chronic renal hypertensive rats. Page:227—233
21. Incidence of post-transplant glomerulonephritis and its impact on graft outcome. Page:219—226
22. Risk factors for mortality in patients with acute kidney injury and hypotension treated with continuous veno-venous hemodiafiltration. Page:214—218
23. Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis. Page:205—213
24. Cytokine gene polymorphisms: Can these differentiate renal disease entities?. Page:203—204
25. A case of biopsy-proven chronic kidney disease on progression from acute phosphate nephropathy. Page:124—127
26. Consecutive episodes of peritonitis in a patient undergoing peritoneal dialysis caused by unusual organisms: Brevibacterium and Pantoea agglomerans. Page:121—123
27. Hemorrhagic fever with renal syndrome and coexisting hantavirus pulmonary syndrome. Page:118—120
28. Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study. Page:112—117
29. Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT. Page:106—111
30. TGF-beta-activated kinase-1: New insights into the mechanism of TGF-beta signaling and kidney disease. Page:94—105
31. Current concepts of the podocyte in nephrotic syndrome. Page:87—93
32. Radiocontrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease. Page:85—86
33. Association between vascular access failure and microparticles in hemodialysis patients. Page:200—201
34. Renal infarction caused by paradoxical embolism through a patent foramen ovale. Page:196—199
35. Laparoscopic biopsy-proven lupus nephritis in autosomal dominant polycystic kidney disease. Page:192—195
36. Hyperuricemia as a marker for progression of immunoglobulin A nephropathy. Page:186—191
37. Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Page:177—185
38. Clinical characteristics of acute renal failure with severe loin pain and patchy renal vasoconstriction. Page:170—176
39. Use of low-dose sulodexide in IgA nephropathy patients on renin-angiotensin system blockades. Page:163—169
40. Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants. Page:157—162
41. Impact of initial blood flow on outcomes of vascular access in hemodialysis patients. Page:151—156
42. Epigenetic modifications and diabetic nephropathy. Page:139—150
43. Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside. Page:132—138
44. Hyperuricemia: A non-traditional risk factor for development and progression of chronic kidney disease?. Page:129—131